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A 67 year old woman developed a fatal febrile illness 8 
years after mitral valve replacement for rheumatic val•
vular heart disease. The final disease persisted for 1 year 
and was characterized clinically by weakness, weight 
loss, congestive heart failure and multiple embolic events 
to the central nervous system and abdominal organs. 
The source of the emboli was a tumor, malignant fibrous 
Tumors of the heart are rare. Their estimated frequency in 
large unselected autopsy series ranges from 0.03 to 0.1 % 
(1). Among such tumors, primary sarcomas are uncommon 
and most are highly malignant and characterized either by 
infiltration of the myocardium or by formation of polypoid 
masses in a heart chamber. Our patient had a malignant 
fibrous histiocytoma of the left atrium, which developed in 
the anulus fibrosus around a prosthetic mitral valve. 
Thromboembolism, prosthesis thrombosis, infective en•
docarditis and complications associated with the obligatory 
anticoagulant therapy, mainly hemorrhage, occur quite fre•
quently after valve replacement. A malignant tumor of the 
heart as a complication has not been reported. Considering 
the potential role of the material covering the valve in tumor 
induction, we suggest the possibility that the tumor found 
in this patient may be regarded as a late complication of 
mitral valve replacement. 
Case Report 
Clinical features. A 68 year old woman with a past 
history of duodenal ulcer and non-insulin-dependent dia•
betes mellitus was admitted to the hospital complaining of 
weakness, low grade fever, loss of weight, palpitation, pre•
cordial pain and shortness of breath. Rheumatic heart dis•
ease with mitral stenosis and insufficiency had been diag-
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histiocytoma of the left atrium, originating from the an•
ulus fibrosus around the covered base of the prosthetic 
valve. This unique case suggests the possibility that chronic 
exposure to materials, such as Dacron, covering pros•
thetic valves may induce local malignant tumors. 
(J Am Coll CardioI1986;7:956-60) 
nosed at age 54. Five years later she developed congestive 
heart failure and the diseased mitral valve was replaced by 
a Starr-Edwards M-3 model 6320 valve. 
Macroscopic examination of the excised valve showed 
thickening of the chordae tendineae and wide areas of cal•
cification. Histologic examination of the fibrotic valve pieces 
demonstrated vascularization, fibrovascular proliferation and 
areas of calcification surrounded by infiltrates of mononu•
clear cells, all compatible with the diagnosis of old rheu•
matic valvulitis. No tumor was detected at careful reex•
amination of the excised valve. Anticoagulant therapy was 
instituted after surgery. Three years later she complained 
of amaurosis fugax of the right eye. 
Eight years after mitral valve replacement (at age 67), 
she developed sudden blindness of the right eye due to 
occlusion of the central retinal artery, and also right hemi•
paresis. She complained of weakness, weight loss, palpi•
tation, headaches and shoulder pain. Results of temporal 
artery biopsy were normal. Corticosteroid therapy was in•
stituted and was followed by deterioration of her diabetes 
requiring insulin treatment. The subsequent course was 
characterized by low grade fever, right heart failure and a 
transient cerebral ischemic attack with right hemiparesis and 
aphasia. The erythrocyte sedimentation rate was accelerated; 
urinalysis showed microscopic hematuria. Urine and blood 
cultures were sterile. The roentgenogram of the chest was 
normal and an intravenous pyelogram revealed a scarred 
right kidney. The echocardiogram did not identify any ab•
normal findings; a bone scan and electroencephalogram were 
normal. Computed tomography of the brain demonstrated 
an infarct in the left lobe. 
On the last admission (at age 68) the patient was weak, 
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febrile and had lost 14 kg in a few weeks. She had atrial 
fibrillation with a rapid ventricular rate, signs of congestive 
heart failure, mild anemia and leukocytosis with normal 
differential count. Platelet count was normal, and there were 
ahaptoglobinemia and prolonged prothrombin time. Kidney 
and liver function tests were normal. Serum thyroxin, com•
plement, calcium, phosphorus, uric acid and cholesterol 
levels were normal. Cryoglobulins were not found. Coombs' 
test and a test for antinuclear antibodies were negative. 
There was no evidence of bacterial, mycobacterial, viral, 
rickettsial or fungal disease in the endocardium or else•
where. The heart shadow was enlarged on X-ray exami•
nation, and an echocardiogram showed normal prosthetic 
valve movements, no vegetations and an enlarged left atrium 
without a space-occupying lesion. Ultrasonography of the 
abdomen and barium enema X-ray study were normal. Liver 
scan was normal and the contour of the spleen on scanning 
was irregular. Steroid therapy was discontinued and the 
patient was treated with warfarin, digitalis and diuretic drugs. 
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Figure 1. Left atrium viewed from above, showing 
the polypoid tumor mass adjacent to the anulus fibrosis 
of the prosthetic valve. . 
On the eighth hospital day reddish spots appeared on her 
palms and soles. "Vasculitis" was diagnosed on the basis 
of skin biopsy, and culture of the biop~ied lesions grew a 
few colonies of Staphylococcus epidermidis. On the 17th 
hospital day she developed an acute abdomen, and on ex•
plorative laparotomy a gangrenous terminal ilium was re•
sected. After surgery the patient developed pulmonary edema, 
shock and acute renal failure and she ~ied 5 days later. 
PathQlogic ~ndings. At autopsy, there was left ventric•
ular hypertrophy with focal pericardial adhesions. There was 
no leakage or thrombosis of the prosthetic mitral valve. Part 
of the anulus fibrosus adjacent to the prosthetic valve ring 
was covered by a sessile polypoid gray fleshy mass, with 
areas of necrosis, measuring 2 x 2 x 5 cm. This extended 
eccentrically toward the left atrial appendage (Fig. 1). Tl1e 
mass penetrated the myocardium. It did not occlude or di•
minish the size of the mitral valve orifice and did not in•
terfere with the pUlmonary veins. 
Histologic examination revealed a cellular tumor with 
Figure 2. Histologic study of the tumor showing 
interlacing bundles of spindle-shaped cells giving a 
storiform pattern (hematoxylin-eosin stain; original 
magnification x 100, requced by 9%). 
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Figure 3. Section of tumor showing cellular pleo•
morphism and giant cells (hematoxylin-eosin stain; 
original magnification x 400. reduced by 9%). 
extensive areas of necrosis (Fig. 2 and 3). It was composed 
of plump blunt-ended spindle fibroblasts with eosinophilic 
cytoplasm and hyperchromatic nuclei, forming fascicles with 
a prominent storiform pattern. In addition, there were po•
lygonal cells and pleomorphic multinucleated giant cells. 
Mitotic figures were numerous. A variable amount of col•
lagen was seen between the tumor cells. The hematoxylin•
eosin and phosphotungstic acid-hematoxylin stains did not 
identify cross striation of muscle. The histologic features 
were those of malignant fibrous histiocytoma. 
No other primary tumor was found in the body and meta•
static dissemination of this tumor was not seen by the naked 
eye. However, histologic examination revealed numerous 
tumor emboli in small arteries with resulting infarction in 
several organs, including the heart, brain, spleen and kid•
neys. No emboli were found in the mesenteric or retinal 
arteries. Reassessment of skin biopsy specimen, originally 
Figure 4. Skin biopsy specimen showing tumor 
emboli in blood vessels (hematoxylin-eosin stain; 
original magnification x 100, reduced by 9%). 
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considered to demonstrate vasculitis, revealed intraarterial 
tumor emboli (Fig. 4). 
Discussion 
Diagnosis. Cardiac tumors occurring in the cavity of the 
atrium usually present clinically in three patterns: a) conges•
tive heart failure, b) thromboembolic episodes and c) con•
stitutional symptoms. This patient had congestive heart fail•
ure and several embolic phenomena to the brain, eye, 
mesentery, kidney and spleen. She had fever, malaise, 
weakness, weight loss and a high sedimentation rate. Ane•
mia, arthralgia, elevated levels of immunoglobulins, Rey•
naud's phenomenon and clubbing have also been described. 
Misdiagnosis on the basis of cutaneous biopsy of a con•
dition such as vasculitis rather than cardiac tumor emboli 
under similar circumstances was reported by Huston et al. 
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(2). They described a patient initially diagnosed as having 
systemic vasculitis on the basis of muscle biopsy but in 
whom emboli from an atrial myxoma were discovered 14 
months later. In another case (3), skin lesions diagnosed as 
hemangioma were later found to be emboli to the skin from 
a cardiac hemangiosarcoma. 
The failure of echocardiography to identify the left atrial 
tumor in this patient is not surprising. The prosthetic valve 
in itself is so intensely echogenic that it prohibits the echo•
cardiographic identification of less echogenic structures in 
its vicinity (4). 
Morphologic features. Malignant fibrous histiocytoma 
is a relatively new diagnostic entity despite its being a com•
mon soft tissue tumor in older adults (5,6). Because of its 
highly variable morphologic patterns, many tumors previ•
ously diagnosed as giant cell sarcoma, pleomorphic sar•
coma, rhabdomyosarcoma of soft tissue or fibrosarcoma are 
probably malignant fibrous histiocytoma. The latter is com•
posed of spindle (fibroblast-like) and rounded (histiocyte•
like) cells in varying proportions arranged in a storiform 
pattern and associated with the presence of pleomorphic 
giant and inflammatory cells. Some investigators (7) have 
suggested that the tumor is of histiocytic origin, others (8) 
that it originates from a primitive mesenchymal cell. 
In about 66% of cases the tumor is found in the limbs, 
and in 16% it is found in the abdominal cavity or retroper•
itoneum (6). Thoracic malignant fibrous histiocytoma is rare, 
but has been described in the lung (9-12), mediastinum (1 \) 
and pericardium (13). Only three cases have been reported 
in the heart (14-16). In all cases the tumor was confined 
to the left atrium and no metastasis or tumor emboli were 
present. One patient underwent five operations for local 
intracardial recurrences and died of heart failure approxi•
mately 3 years after the initial presentation ( 15). 
Etiologic role of prosthetic heart valves. The first suc•
cessful replacement of the mitral valve occurred in 1961 
(17). Since then it became a common procedure in the 
treatment of valvular disease. Currently, approximately 30,000 
heart valves are replaced annually in the United States and 
more than 70,000 throughout the world (18). The type of 
prosthesis used in our patient is covered with knitted Dacron 
cloth and has been in use since 1967. 
The role of prosthetic grafts in tumor genesis was in•
vestigated by Oppenheimer et al. (19). Abdominal subcu•
taneous implantation of plastic discs in rodents induced for•
mation of fibrosarcoma in the fibrous capsule around the 
disc, and a transition among proliferating fibroblasts, pro•
gressive cellular atypia and sarcoma were demonstrated. All 
plastic polymers tested in their study, including Dacron. 
induced fibrosarcoma in significant numbers after a latent 
period varying from 7 months to 2V2 years. It is not known 
whether these or similar materials can induce sarcomas in 
humans. Sarcomas rising in the aorta and large arteries are 
extremely rare. Only 18 cases have been reported. In five 
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of these cases (20-24) sarcoma of the aorta (including one 
malignant fibrous histiocytoma) occurred adjacent to a Dac•
ron graft 4 months to 12 years after implantation. Malignant 
fibrous histiocytoma was reported (25) to have arisen at the 
site of a metal implant inserted 14 years previously for 
traumatic fracture of the femur. 
The animal experiments (19) and the vascular sarcomas 
in humans suggest that plastic polymers may be an etiologic 
factor in the development of these tumors. Malignant fibrous 
histiocytoma has been induced by injections of 4-hydrox•
yaminoquinolin I-oxide in rats (26), suggesting that chem•
ical carcinogenesis may be important in the development of 
the tumor. The paucity of reported cases in spite of the 
widespread use of Dacron and synthetic polymers in grafts 
and prosthetic valves does not support a strong carcinogenic 
potential of these materials in humans; however, it certainly 
does not rule it out. The absence of left atrial tumor at the 
time of valve replacement and the proximity of the site of 
the tumor to the prosthetic valve support a possible relation. 
Animal experiments (19) showed a relatively long latent 
period between the implantation of synthetic polymer and 
the development of the tumor. If this is also true in humans 
it is not unreasonable, with time. to expect an increased 
incidence of these cases. Time will also tell whether we 
have uncovered a new late complication of valve replace•
ment or a coincidental development of an extremely rare 
tumor next to an artificial valve. 
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